Catheter Precision Net Worth
Catheter Precision Net Worth Breakdown | VTAK |
Catheter Precision Net Worth Analysis
Catheter Precision's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Catheter Precision's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Catheter Precision's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Catheter Precision's net worth analysis. One common approach is to calculate Catheter Precision's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Catheter Precision's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Catheter Precision's net worth. This approach calculates the present value of Catheter Precision's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Catheter Precision's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Catheter Precision's net worth. This involves comparing Catheter Precision's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Catheter Precision's net worth relative to its peers.
To determine if Catheter Precision is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Catheter Precision's net worth research are outlined below:
| Catheter Precision generated a negative expected return over the last 90 days | |
| Catheter Precision has high historical volatility and very poor performance | |
| Catheter Precision has some characteristics of a very speculative penny stock | |
| Catheter Precision has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 442 K. Net Loss for the year was (70.57 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Catheter Precision generates negative cash flow from operations | |
| Catheter Precision has a frail financial position based on the latest SEC disclosures | |
| About 14.0% of the company outstanding shares are owned by insiders | |
| Latest headline from news.google.com: Catheter Precision expands share authorization and warrant exercise - Investing.com |
Catheter Precision uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Catheter Precision. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Catheter Precision's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Follow Catheter Precision's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.76 M.Market Cap |
|
Project Catheter Precision's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (18.37) | (17.45) | |
| Return On Capital Employed | (3.18) | (3.34) | |
| Return On Assets | (2.64) | (2.77) | |
| Return On Equity | (3.83) | (3.64) |
When accessing Catheter Precision's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Catheter Precision's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Catheter Precision's profitability and make more informed investment decisions.
Evaluate Catheter Precision's management efficiency
Catheter Precision has return on total asset (ROA) of (0.2156) % which means that it has lost $0.2156 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4981) %, meaning that it created substantial loss on money invested by shareholders. Catheter Precision's management efficiency ratios could be used to measure how well Catheter Precision manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is expected to rise to -17.45 this year. The value of Return On Capital Employed is expected to slide to -3.34. At this time, Catheter Precision's Total Current Liabilities is quite stable compared to the past year. Change To Liabilities is expected to rise to about 474.5 K this year, although the value of Liabilities And Stockholders Equity will most likely fall to about 32.6 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 4.44 | 4.21 | |
| Tangible Book Value Per Share | (1.07) | (1.02) | |
| Enterprise Value Over EBITDA | (1.13) | (1.19) | |
| Price Book Value Ratio | 0.94 | 0.99 | |
| Enterprise Value Multiple | (1.13) | (1.19) | |
| Price Fair Value | 0.94 | 0.99 | |
| Enterprise Value | 17.1 M | 15.2 M |
Evaluating the management effectiveness of Catheter Precision allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Catheter Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Enterprise Value Revenue 10.7522 | Revenue | Quarterly Revenue Growth (0.03) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Catheter Precision insiders, such as employees or executives, is commonly permitted as long as it does not rely on Catheter Precision's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Catheter Precision insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Anderson Philip J over a week ago Insider Trading | ||
David Jenkins over six months ago Purchase by David Jenkins of 9528 shares of Catheter Precision | ||
David Jenkins over a year ago Purchase by David Jenkins of 7793 shares of Catheter Precision | ||
Thomassen Margrit over a year ago Catheter Precision exotic insider transaction detected |
Catheter Precision Earnings per Share Projection vs Actual
Catheter Precision Corporate Management
| Patricia Kennedy | Chief Officer | Profile | |
| Missiaen Huck | Chief Officer | Profile | |
| Margrit CPA | Interim Secretary | Profile | |
| MarieClaude Jacques | Chief Officer | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Catheter Precision. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Catheter Stock please use our How to buy in Catheter Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Catheter Precision. If investors know Catheter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Catheter Precision listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 30.61 | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets | Return On Equity |
The market value of Catheter Precision is measured differently than its book value, which is the value of Catheter that is recorded on the company's balance sheet. Investors also form their own opinion of Catheter Precision's value that differs from its market value or its book value, called intrinsic value, which is Catheter Precision's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Catheter Precision's market value can be influenced by many factors that don't directly affect Catheter Precision's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Catheter Precision's value and its price as these two are different measures arrived at by different means. Investors typically determine if Catheter Precision is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Catheter Precision's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.